Coronary CT Angiography Protocol
Coronary CTA requires intravenous iodinated contrast (50-160 mL at 4-6 mL/s), premedication with beta-blockers to achieve heart rate ≤60 bpm, and sublingual nitroglycerin for coronary vasodilation, with critical attention to radiation dose optimization and patient-specific contraindications. 1
Contrast Administration Protocol
The standard protocol involves 60-100 mL of iodinated contrast medium (typically 320 mg Iodine/mL for coronary CTA) injected at 4-6 mL/s through an 18-gauge or larger antecubital IV cannula. 1, 2
Contrast Timing and Delivery
- Accurate timing is the major determinant of image quality—use either a test bolus (10-20 mL) to measure time to peak aortic root enhancement, or automated bolus tracking that triggers scanning when aortic enhancement exceeds a predetermined threshold 1
- For CCTA specifically, administer 50-150 mL at 4-7 mL/s with bolus tracking or test bolus technique 2
- Weight-adjusted protocols (1.0 mL/kg with 15-second injection duration) provide more consistent enhancement across different body weights compared to fixed-dose protocols, with significantly better image quality and fewer beam-hardening artifacts 3
- Even reduced volumes (60 mL vs 80 mL) achieve adequate enhancement (>300 HU) in >96% of coronary segments when using 370 mg I/mL contrast 4
Contrast-Related Caveats
- Exclude patients with compromised renal function due to nephrotoxicity risk, as they may subsequently require invasive angiography 1
- Risk of anaphylactoid reactions to iodinated contrast 1
- Do not mix contrast with other drugs or total nutritional admixtures in IV lines 2
- Warm contrast to body or room temperature before administration 2
- Maximum recommended total iodine dose for adults is 80 grams 2
Pharmacological Premedication
Beta-Blocker Administration (Primary Heart Rate Control)
Administer beta-blockers (oral 60-90 minutes before scan or IV immediately before) to achieve heart rate ≤60 bpm, which is essential for minimizing motion artifacts on scanners with temporal resolution ≥250 ms. 1
- Target heart rate depends on scanner temporal resolution:
- Metoprolol is the beta-blocker of choice, effective in achieving goal heart rate and minimizing heart rate variability 5
Beta-blocker contraindications and cautions:
- Absolute contraindications: hypotension, high-degree AV block 5
- Use with extreme caution in: asthma/obstructive pulmonary disease, decompensated heart failure, vasospastic or vasoocclusive disease 5
- May be contraindicated in aortic stenosis—consult referring cardiologist 6
- For patients with asthma/bronchospastic disease or sympathetically denervated orthotopic heart transplants, consider diltiazem (calcium channel blocker) as alternative 5
Nitroglycerin Administration (Coronary Vasodilation)
Administer sublingual nitroglycerin (0.3-0.4 mg) immediately before scanning to achieve coronary vasodilation and improve image quality, particularly for distal vessel visualization. 1, 6
- Shown to improve image quality in coronary CTA studies 1
- Especially useful for dilating distal arteries to improve stenosis visibility 5
Nitroglycerin contraindications and cautions:
- Absolute contraindications: recent phosphodiesterase inhibitor use (erectile dysfunction medications), severe anemia 6, 5
- Use cautiously in: aortic stenosis or other preload-dependent cardiac pathologies 6, 5
- Can cause systemic hypotension leading to reflex tachycardia and worsening myocardial ischemia 6
- Do NOT routinely administer for non-coronary cardiac CT (endocarditis, device evaluation) in hemodynamically unstable patients 6
- Remove all transdermal nitroglycerin patches from chest before defibrillation to prevent arcing 6
Technical Acquisition Parameters
Patient Preparation
- Hydrate patients before and after contrast administration 2
- ECG monitoring equipment required for gating 7
- Patients must be able to hold breath for 8-20 seconds during acquisition (though high-pitch dual-source CT can be performed during free breathing in patients with heart rate ≤60 bpm without substantial image quality loss) 1, 8
- Exclude patients with irregular cardiac rhythm or heart rate >100 bpm 2
Image Acquisition
- Spatial resolution: 0.4 mm with 64-slice MDCT (submillimeter resolution achieved with 16-320 slice scanners) 1
- Retrospective ECG gating used to reconstruct images during phase of cardiac cycle with least motion 1
- Scan duration: 8-20 seconds depending on scanner generation 1
Critical Caveats and Limitations
Image Quality Limitations
- Heavy coronary calcification causes false-positive findings and may render segments non-evaluable for stenosis assessment 1
- Coronary stents create artifacts that preclude adequate lumen visualization 1
- Motion artifacts from high heart rates or arrhythmias significantly degrade image quality 1
- Poor acoustic windows or respiratory motion can compromise diagnostic quality 1
Radiation Exposure
Coronary CTA exposes patients to considerably higher radiation than standard radiographs, calcium scoring, or invasive angiography (effective dose 10-21 mSv depending on technique and patient sex). 1
- Radiation dose reduction strategies:
- Particularly concerning in pediatric patients due to higher projected lifetime cancer mortality risk—use bismuth breast shielding in female children (reduces breast exposure 40%) 1
- Inappropriate for very low-risk populations where radiation risk may exceed benefit 1
Patient Selection Exclusions
- Compromised renal function (contrast nephrotoxicity) 1
- Inability to cooperate with breath-holding (though free-breathing protocols exist for low heart rates) 8
- Severe obesity may require increased radiation dose for adequate image quality 1
- Avoid extravasation, especially in patients with severe arterial/venous disease 2